SCHEMBL25286339

SCHEMBL25286339

CCCCCCCCCCCCCCCCCC(O)COC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TK1 P04183 2/20 0.48
CSNK1E P49674 1/20 0.42
GPR84 Q9NQS5 4/20 0.40
PRSS1 P07477 2/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
PLA2G2A P14555 2/20 0.39
PLA2G10 O15496 1/20 0.39
PLA2G1B P04054 1/20 0.39
PLA2G5 P39877 1/20 0.39
CTSK P43235 2/20 0.39
FFAR4 Q5NUL3 1/20 0.39
FFAR1 O14842 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CTSG P08311 1/20 0.38
CTRB1 P17538 1/20 0.38
CMA1 P23946 1/20 0.38
KIF11 P52732 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25293956 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25077460 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25077369 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25284468 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25077153 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25077124 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25245658 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25077399 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25077111 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2
SCHEMBL25077325 1.00 TK1 (0.48) TK1CSNK1EGPR84PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034182-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2025-01-30 US disclosed
US-12116380-B2 Phospholipid compounds and methods of making and using the same GILEAD SCIENCES, INC. (US) 2024-10-15 US disclosed
CN-117858881-A Phospholipid compounds and methods of making and using the same 吉利德科学公司 2024-04-09 CN disclosed
US-20230212199-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME GILEAD SCIENCES, INC. 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12116380-B2 Phospholipid compounds and methods of making and using the same PHOSPHO1, SGMS1, SGMS2 TK1 940/4885CSNK1E 4339/4885GPR84 3385/4885
US-20230212199-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PHOSPHO1, SGMS1, SGMS2 TK1 940/4885CSNK1E 4339/4885GPR84 3385/4885
US-20250034182-A1 PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME PHOSPHO1, SGMS1, SGMS2 TK1 940/4885CSNK1E 4339/4885GPR84 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.